Geoffrey A. Swire
Geschäftsführer bei ALLENA PHARMACEUTICALS, INC.
Aktive Positionen von Geoffrey A. Swire
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLENA PHARMACEUTICALS, INC. | Geschäftsführer | 10.11.2020 | - |
Corporate Officer/Principal | 01.01.2018 | - |
Karriereverlauf von Geoffrey A. Swire
Ehemalige bekannte Positionen von Geoffrey A. Swire
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
RADIUS HEALTH, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Geoffrey A. Swire
Dartmouth College | Undergraduate Degree |
Harvard University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALLENA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Geoffrey A. Swire
- Erfahrung